Ledger.Open graph →
SEC Form D · filed April 28, 2014

Avalanche Biotechnologies, Inc

Offering
$56.0M
Sold
$55.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Menlo Park, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Paul D. Wachter · Menlo Park, CADirectorJohn D. Mclaughlin · Menlo Park, CADirectorSteven D. Schwartz · Menlo Park, CADirectorMark S. Blumenkranz · Menlo Park, CADirectorThomas W. Chalberg · Menlo Park, CAExec · DirectorDan Novaes · Chicago, ILExec · DirectorNick Mcevily · Chicago, ILDirectorWilliam Engles · Boca Raton, FLDirectorScott Barry · NEW YORK, NYDirectorPetri Vainio, M.D., Ph.D · NEW YORK, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗